PDD vs RNAC · P/E 8.4, rev $61.75B vs P/E 2.1, rev $38.9M
PDD Holdings Inc. (PDD) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
PDD currently screens at market cap $113.67B and trailing P/E 8.4. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the PDD and RNAC stock pages for the full models.
Not investment advice.